New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
06:33 EDTCCGCampus Crest downgraded to Hold from Buy at MLV & Co.
MLV & Co downgraded Campus Crest following the Q2 loss and guidance reduction.
News For CCG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
08:37 EDTCCGClinton Group, Campus Evolution sends open letter to Campus Crest shareholders
Subscribe for More Information
February 26, 2015
06:48 EDTCCGCampus Crest sees FY15 pro rata NOI ex-Montreal $117M-$122M
Subscribe for More Information
06:46 EDTCCGCampus Crest reports Q4 FFOA 5c, consensus 15c
Reports Q4 revenue $28.73M, consensus $28.26M.
February 23, 2015
09:31 EDTCCGClinton, Campus Evolution Villages to file preliminary proxy on Campus Crest
Subscribe for More Information
February 17, 2015
18:36 EDTCCGCampus Crest responds to Clinton Group, Campus Evolution Villages
Subscribe for More Information
10:00 EDTCCGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTCCGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop Holdings (VIPS), up 10.9%... VASCO Data Security (VDSI), up 7.1%... Waste Management (WM), up 3.7%. ALSO HIGHER: Starwood Hotels (HOT), up 1.9% after appointing Adam Aron as interim CEO... Sarepta Therapeutics (SRPT), up 7.3% after being upgraded at BofA/Merrill... Navidea Biopharmaceuticals (NAVB), up 7.5% after publishing results of phase 3 Lymphoseek trial... Campus Crest (CCG), up 7.7% after announcing that it will explore strategic alternatives as well as Clinton Group and Campus Evolution proxy contest... Cyren (CYRN), up 7.1% following distribution agreement with ALSO Deutschland. DOWN AFTER EARNINGS: Helix Energy (HLX), down 13.3%... Walter Energy (WLT), down 10.1%. ALSO LOWER: Celsus Therapeutics (CLTX), down 82.3% after MRX-6 Cream 2% Phase II trial did not meet primary endpoint... Vascular Biogenics (VBLT), down 53.2% after reporting that VB-201 Phase 2 studies did not meet primary endpoints and removal of FDA partial clinical hold on VB-111... Vanguard Natural Resources (VNR), down 7.1% after reporting preliminary fourth quarter results.
09:12 EDTCCGClinton Group, Campus Evolution announce proxy contest at Campus Crest
Subscribe for More Information
06:09 EDTCCGCampus Crest upgraded to Buy from Hold at Wunderlich
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use